Semler Scientific, Inc. (SMLR)

Market Cap	168.16M
Revenue (ttm)	61.74M
Net Income (ttm)	15.82M
Shares Out	6.99M
EPS (ttm)	2.03
PE Ratio	11.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,887
Open	24.01
Previous Close	24.15
Day's Range	23.65 - 24.42
52-Week Range	20.88 - 53.38
Beta	0.96
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company’s products serve cardiologists, internists, ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 92
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2023, Semler Scientific's revenue was $68.18 million, an increase of 20.28% compared to the previous year's $56.69 million. Earnings were $20.58 million, an increase of 43.69%.